Affluent Medical SA (EPA:AFME)

France flag France · Delayed Price · Currency is EUR
1.500
-0.025 (-1.64%)
Sep 26, 2025, 5:36 PM CET
-1.64%
Market Cap59.02M
Revenue (ttm)5.35M
Net Income (ttm)-14.74M
Shares Out39.35M
EPS (ttm)-0.41
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume7,093
Average Volume7,853
Open1.525
Previous Close1.525
Day's Range1.500 - 1.635
52-Week Range1.160 - 1.970
Beta0.71
RSI48.09
Earnings DateSep 26, 2025

About Affluent Medical

Affluent Medical SA, a medical technology company, develops and markets minimally invasive minimally invasive medical devices in the field of urology and structural heart in France. The company offers Artus, an implantable electro-mechanical artificial sphincter that targets moderate to severe urinary incontinence; and Kalios and Epygon implants for the treatment of mitral insufficiency, as well as Kardiozis technology for treating abdominal aortic aneurysm. Affluent Medical SA was founded in 2011 and is headquartered in Aix-en-Provence, France... [Read more]

Sector Healthcare
Founded 2011
Employees 78
Stock Exchange Euronext Paris
Ticker Symbol AFME
Full Company Profile

Financial Performance

In 2024, Affluent Medical's revenue was 5.35 million, an increase of 337.09% compared to the previous year's 1.22 million. Losses were -14.74 million, -5.84% less than in 2023.

Financial Statements

News

There is no news available yet.